Relating to: regulating hemp-derived cannabinoid products.
Failed to pass pursuant to Senate Joint Resolution 1
Email me when AB 747 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track AB 747. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would set strict standards for any hemp‑derived cannabinoid product sold in the state, including mandatory lab testing, detailed labeling, child‑proof packaging, and a ban on sales to anyone under 21. It applies to manufacturers, retailers, and distributors, aiming to protect public health and prevent minors from accessing these products.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about AB 747
3 free questions a day, no accountHistory
- Failed to pass pursuant to Senate Joint Resolution 1
- Representative Kirsch added as a coauthor
- Assembly Amendment 1 offered by Representative Kurtz
- Representative Knodl added as a coauthor
- Representative Kreibich added as a coauthor
- Representative Tucker added as a coauthor
- Representative Ortiz-Velez added as a coauthor
- Representatives Neylon and Hong added as coauthors
- Representative Udell added as a coauthor
- Senator Quinn added as a cosponsor
- Read first time and referred to Committee on State Affairs
- Introduced by Representatives Kurtz, Sortwell, Hysell, Duchow, Kaufert, Murphy, Roe, Sinicki and Stroud; cosponsored by Senator Testin
Sponsors
- Kurtz · sponsor
- Duchow
- Hysell
- Kaufert
- Murphy
- Roe
- Sinicki
- Sortwell
- Stroud
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when AB 747 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track AB 747 freeOr ask your AI assistant about AB 747 directly:
Add to Claude, ChatGPT or Cursor